Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Nov. 3, 2022
Abstract
The
5-year
survival
rate
of
patients
with
head
and
neck
squamous
cell
carcinoma
(HNSCC)
remains
<50%
due
to
risk
the
recurrence
metastasis.
Hypoxia
patterns
are
a
hallmark
HNSCC
that
associated
its
occurrence
progression.
However,
precise
role
hypoxia
during
HNSCC,
such
as
relationship
between
hypoxia,
tumor
immune
landscape
communication
orchestration
largely
unknown.
current
study
integrated
data
from
bulk
single-cell
RNA
sequencing
analyses
define
HNSCC.
First,
scoring
system
named
score
(HS)
was
constructed
based
on
hypoxia-related
genes
(HRGs)
expression.
outcomes,
stromal/immune/Estimate
scores,
responses
targeted
inhibitors,
chemotherapeutic,
immunotherapy
were
distinct
high
HS
group
low
group.
Single-cell
datasets
showed
different
distributions
in
populations.
Furthermore,
HLA-DPA1/CD4
axis
identified
unique
interaction
CD4+
T
Conv
pDC
cells.
These
findings
may
enhance
understanding
characteristics
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Nov. 22, 2022
Immunotherapy
has
revolutionized
colon
cancer
treatment.
Immune
checkpoint
inhibitors
(ICIs)
have
shown
clinical
benefits
for
patients,
especially
those
with
high
microsatellite
instability
(MSI-H).
In
2020,
the
US
Food
and
Drug
Administration
(FDA)-approved
ICI
pembrolizumab
as
first-line
treatment
metastatic
MSI-H
patients.
Additionally,
neoadjuvant
immunotherapy
presented
efficacy
in
treating
early-stage
Although
MSI
been
thought
of
an
effective
predictive
biomarker
immunotherapy,
only
a
small
proportion
patients
were
MSI-H,
certain
intrinsic
or
acquired
resistance
to
immunotherapy.
Thus,
further
search
biomarkers
stratify
is
meaningful
Except
MSI,
other
biomarkers,
such
PD-L1
expression
level,
tumor
mutation
burden
(TMB),
tumor-infiltrating
lymphocytes
(TILs),
gut
microbiota,
ctDNA,
circulating
immune
cells
also
proposed
be
correlated
patient
survival
some
studies.
Moreover,
developing
new
diagnostic
techniques
helps
identify
accurate
this
review,
we
outline
reported
discuss
prospects
technological
changes
development
Medicinal Research Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 9, 2025
ABSTRACT
Proteins
hold
pivotal
importance
since
many
diseases
manifest
changes
in
protein
activity.
Proteomics
techniques
provide
a
comprehensive
exploration
of
structure,
abundance,
and
function
biological
samples,
enabling
the
holistic
characterization
overall
organisms.
Nowadays,
breadth
emerging
methodologies
proteomics
is
unprecedentedly
vast,
with
constant
optimization
technologies
sample
processing,
data
collection,
analysis,
its
scope
application
steadily
transitioning
from
bench
to
clinic.
Here,
we
offer
an
insightful
review
technical
developments
applications
biomedicine
over
past
5
years.
We
focus
on
profound
contributions
profiling
disease
spectra,
discovering
new
biomarkers,
identifying
promising
drug
targets,
deciphering
alterations
conformation,
unearthing
protein–protein
interactions.
Moreover,
summarize
cutting‐edge
potential
breakthroughs
pipeline
principal
challenges
proteomics.
Based
these,
aspire
broaden
applicability
inspire
researchers
enhance
our
understanding
complex
systems
by
utilizing
such
techniques.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(6)
Published: May 23, 2024
Abstract
Cancer
is
one
of
the
leading
causes
death
worldwide,
and
more
effective
ways
attacking
cancer
are
being
sought.
immunotherapy
a
new
therapeutic
method
after
surgery,
radiotherapy,
chemotherapy,
targeted
therapy.
aims
to
kill
tumor
cells
by
stimulating
or
rebuilding
body's
immune
system,
with
specific
efficiency
high
safety.
However,
only
few
patients
respond
due
complex
variable
characters
escape,
behavior
regulatory
mechanisms
need
be
deeply
explored
from
dimensions.
Epigenetic
modifications,
metabolic
modulation,
cell‐to‐cell
communication
key
factors
in
cell
adaptation
response
microenvironment.
They
collectively
determine
state
function
through
modulating
gene
expression,
changing
energy
nutrient
demands.
In
addition,
engage
networks
other
components,
which
mediated
exosomes,
cytokines,
chemokines,
pivotal
shaping
progression
response.
Understanding
interactions
combined
effects
such
multidimensions
modulation
important
for
revealing
failure
developing
targets
strategies.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 11, 2025
Hepatocellular
carcinoma
(HCC)
is
known
for
its
high
invasiveness,
fatality
rate.
Both
hypoxia
and
senescence
play
crucial
roles
in
the
initiation
progression
of
cancer,
yet
their
prognostic
implications
HCC
are
to
be
fully
understood.
The
hypoxia-senescence
co-related
genes
(HSCRGs)
were
screened
from
public
databases.
Transcriptome
data
clinical
information
obtained
patients
with
using
Cancer
Genome
Atlas,
GSE76427,
International
Consortium
(ICGC).
random
forest
tree
algorithm
was
used
identify
characteristic
disease,
verified
by
related
experiments.
SVM
classify
based
on
HSCRGs.
prediction
model
HSCRGs
established
LASSO,
univariate
multivariate
COX
regression
analysis.
We
ICGC
outside
validation.
risk
score
analyzed
subgroup
analysis,
immune
infiltration,
functional
strength.
expression
patterns
key
tumor
microenvironment
decoded
single
cell
A
total
184
identified.
pattern
characteristics
MLH1
gene
verified.
Two
subtypes
identified
Then,
a
established,
as
an
independent
indicator
HCC.
new
nomogram
constructed
shows
good
ability.
further
determined
that
level
infiltration
cells
checkpoints
significantly
affected
score.
different
between
two
groups.
high-risk
group
dominated
immunosuppressed
cells,
prognosis
poor.
Single-cell
analysis
revealed
seven
microenvironment.
Finally,
qPCR
results
levels
genes.
great
significance
prediction,
stratification
targeted
therapy
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: Aug. 10, 2022
Background
Prostate
cancer
(PCa)
is
among
the
leading
causes
of
death
worldwide.
Ferroptosis
refers
to
an
iron-dependent
form
regulated
cell
and
involved
in
prostate
tumorigenesis.
A
few
ferroptosis-related
gene
signatures
have
been
developed
predict
prognosis
for
PCa
patients.
However,
previous
were
typically
established
based
on
biochemical
recurrence-free
survival,
which
has
proven
not
be
a
good
surrogate
overall
survival
(OS).
This
study
aimed
construct
novel
prognostic
index
(FRGPI)
disease-free
(DFS)
response
immunotherapy
patients
after
radical
prostatectomy.
Methods
Gene
expression
clinicopathological
data
obtained
from
TCGA
database.
Ferroptosis-related
hub
genes
associated
with
DFS
identified
by
in-depth
bioinformatics
analysis
using
comprehensive
algorithm
functional
enrichment,
consensus
clustering,
weighted
co-expression
network
(WGCNA),
protein-protein
interaction
(PPI)
construction.
The
FRGPI
was
basis
selected
multivariate
cox
regression
further
validated
two
additional
cohorts.
Next,
clinicopathological,
molecular,
immune
profiles
characterized
compared
between
FRGPI-high
FRGPI-low
subgroups.
Finally,
predictive
role
estimated
metastatic
urothelial
cohort
treated
anti-PD-L1
agent.
Results
constructed
four
(E2F1,
CDC20,
TYMS,
NUP85),
had
worse
than
Multivariate
revealed
that
could
act
as
independent
factor
nomogram
comprising
other
parameters
quantitatively.
In
addition,
results
demonstrated
high
scores
showed
significantly
positive
correlation
features,
higher
mutation
counts,
increased
frequency
copy
number
variations
(CNVs),
homologous
recombination
deficiency
(HRD)
scores,
mRNAsi,
more
importantly,
enhanced
sensitivity
immunotherapy.
Conclusions
only
promising
robust
biomarker,
but
also
potential
indicator
immunotherapeutic
outcomes
Translational Oncology,
Journal Year:
2023,
Volume and Issue:
36, P. 101741 - 101741
Published: July 29, 2023
Many
studies
have
demonstrated
the
crucial
roles
of
5-methylcytosine
(m5C)
RNA
methylation
in
cancer
pathogenesis.Two
datasets,
including
TCGA-KIRP
and
ICGC,
related
clinical
information
were
downloaded,
where
expression
13
m5C
regulators
was
examined.
We
applied
LASSO
regression
to
construct
a
multi-m5C-regulator-based
signature
TCGA
cohort,
which
further
validated
using
ICGC
cohort.
Univariate
multivariate
Cox
regressions
evaluate
independent
prognostic
value
our
model.
The
differences
biological
functions
immune
characterizations
between
high
low-risk
groups
divided
based
on
risk
scores
also
investigated
via
multiple
approaches,
such
as
enrichment
analyses,
mutation
mining,
scoring.
Finally,
sensitivities
commonly
used
targeted
drugs
tested,
connectivity
MAP
(cMAP)
utilized
screen
potentially
effective
molecules
for
patients
high-risk
group.
Experimental
validation
done
following
qPCR
tests
Caki-2
HK-2
cell
lines.3
regulators,
ALYREF,
DNMT3B
YBX1,
involved
Survival
analysis
revealed
worse
prognosis
results
indicated
model's
superior
predictive
performance
compared
single-factor
evaluation.
Functional
analyses
higher
frequency
poorer
tumor
microenvironment
qPCR-based
that
DNMT3B,
YBX1
significantly
up-regulated
lines
with
lines.
Molecules
like
BRD-K72451865,
Levosimendan,
BRD-K03515135
advised
by
cMAP
group.Our
study
presented
novel
model
KIRP
prognosis.
Furthermore,
provide
new
insights
investigating
events
pathogenesis.